FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116573006: Betamethasone sodium phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177225012 Betamethasone sodium phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679783016 Betamethasone sodium phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
177225012 Betamethasone sodium phosphate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
177225012 Betamethasone sodium phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679783016 Betamethasone sodium phosphate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
679783016 Betamethasone sodium phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
37151000188118 bétaméthasone phosphate disodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
794651000172110 phosphate sodique de bétaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
37151000188118 bétaméthasone phosphate disodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
794651000172110 phosphate sodique de bétaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone sodium phosphate Is a Betamethasone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is a Pregnane (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is a Synthetic glucocorticoid, fluorinated false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is modification of (attribute) Betamethasone true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Has disposition Immunomodulator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is a Immunomodulator true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is a Fluorinated corticosteroid true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is a Glucocorticoid (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Has disposition Hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Betamethasone sodium phosphate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate [ear] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 4mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 15mg/5mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 3mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
bétaméthasone 4 mg/mL, ampoule de 1 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 3mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) Has precise active ingredient True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) Has basis of strength substance (attribute) True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone sodium phosphate 1 mg/g eye ointment Has precise active ingredient True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone sodium phosphate 1 mg/g eye ointment Has basis of strength substance (attribute) True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) Has precise active ingredient True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) Has basis of strength substance (attribute) True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient True Betamethasone sodium phosphate Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start